BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,067 filers reported holding BAXTER INTL INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $233,000 | -22.6% | 3,625 | -6.5% | 0.04% | -4.3% |
Q1 2022 | $301,000 | -18.0% | 3,879 | -9.3% | 0.05% | -19.3% |
Q4 2021 | $367,000 | -2.4% | 4,279 | -8.5% | 0.06% | -12.3% |
Q3 2021 | $376,000 | -0.3% | 4,679 | 0.0% | 0.06% | +1.6% |
Q2 2021 | $377,000 | -13.1% | 4,679 | -9.1% | 0.06% | -19.0% |
Q1 2021 | $434,000 | +3.8% | 5,145 | -1.2% | 0.08% | -4.8% |
Q4 2020 | $418,000 | -7.1% | 5,207 | -6.9% | 0.08% | -21.0% |
Q3 2020 | $450,000 | +4.9% | 5,590 | +12.3% | 0.10% | -22.2% |
Q2 2020 | $429,000 | +4.1% | 4,978 | -2.0% | 0.14% | -4.9% |
Q1 2020 | $412,000 | -8.4% | 5,078 | -5.6% | 0.14% | +18.3% |
Q4 2019 | $450,000 | -4.3% | 5,378 | 0.0% | 0.12% | -12.4% |
Q3 2019 | $470,000 | +4.7% | 5,378 | -1.8% | 0.14% | +5.4% |
Q2 2019 | $449,000 | +0.9% | 5,478 | 0.0% | 0.13% | -3.0% |
Q1 2019 | $445,000 | +23.3% | 5,478 | 0.0% | 0.13% | +16.5% |
Q4 2018 | $361,000 | -14.5% | 5,478 | 0.0% | 0.12% | -5.0% |
Q3 2018 | $422,000 | +0.7% | 5,478 | -3.5% | 0.12% | -8.3% |
Q2 2018 | $419,000 | – | 5,678 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |